The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.
www.marketwatch.com
#Pharma #stocks #advance #Trump #rolls #drugpricing #deals #companies
Related Posts

BMO Favors MongoDB (MDB) for Non-Relational Database Strength, Sets $280 Target
MongoDB Inc. (NASDAQ:MDB) is one of the best large-cap tech stocks to buy now. Although MongoDB’s core strength as a modern,…

What Trump’s ‘big beautiful bill’ means for higher education
ContentsRead more CNBC personal finance coverageNew grads face a challenging job marketHow the ‘big beautiful bill’ may impact higher education…

Jim Cramer Says He is “Not a Fan of Kohl’s”
ContentsRead more CNBC personal finance coverageNew grads face a challenging job marketHow the ‘big beautiful bill’ may impact higher education…

